AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.verified

AXIM

Price:

$0.022

Market Cap:

$7.33M

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing...[Read more]

Industry

Biotechnology

IPO Date

2014-09-02

Stock Exchange

OTC

Ticker

AXIM

The Enterprise Value as of December 2025 (TTM) for AXIM Biotechnologies, Inc. (AXIM) is 14.70M

According to AXIM Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.70M. This represents a change of 67.63% compared to the average of 8.77M of the last 4 quarters.

AXIM Biotechnologies, Inc. (AXIM) Historical Enterprise Value (quarterly & annually)

How has AXIM Enterprise Value performed in the past?

The mean historical Enterprise Value of AXIM Biotechnologies, Inc. over the last ten years is 109.35M. The current 14.70M Enterprise Value has changed 1.24% with respect to the historical average. Over the past ten years (40 quarters), AXIM's Enterprise Value was at its highest in in the March 2017 quarter at 707.27M. The Enterprise Value was at its lowest in in the December 2024 quarter at 7.25M.

Quarterly (TTM)
Annual

Average

109.35M

Median

37.61M

Minimum

7.25M

Maximum

497.33M

AXIM Biotechnologies, Inc. (AXIM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AXIM Biotechnologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.83%

Maximum Annual Enterprise Value = 497.33M

Minimum Annual Increase = -96.24%

Minimum Annual Enterprise Value = 7.25M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20247.25M-28.00%
202310.06M-1.34%
202210.20M-83.87%
202163.22M17.89%
202053.63M90.16%
201928.20M-40.03%
201847.02M-90.54%
2017497.33M36.58%
2016364.13M2.83%
201512.43M-96.24%

AXIM Biotechnologies, Inc. (AXIM) Average Enterprise Value

How has AXIM Enterprise Value performed in the past?

The current Enterprise Value of AXIM Biotechnologies, Inc. (AXIM) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.17M

5-year avg

28.87M

10-year avg

109.35M

AXIM Biotechnologies, Inc. (AXIM) Enterprise Value vs. Peers

How is AXIM’s Enterprise Value compared to its peers?

AXIM Biotechnologies, Inc.’s Enterprise Value is greater than Acrux Limited (9.34M), greater than HAVN Life Sciences Inc. (487.77K), greater than ProtoKinetix, Incorporated (1.96M), greater than Zelira Therapeutics Limited (6.18M), greater than Sigyn Therapeutics, Inc. (5.94M), greater than ReNeuron Group plc (-5684885.21), greater than RepliCel Life Sciences Inc. (2.20M), greater than Polarean Imaging plc (-9152404.61), less than Radient Technologies Inc. (0), greater than LiveWire Ergogenics, Inc. (4.73M),

Build a custom stock screener for AXIM Biotechnologies, Inc. (AXIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AXIM Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AXIM Biotechnologies, Inc. (AXIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AXIM Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AXIM Biotechnologies, Inc.'s Enterprise Value?

What is the highest Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?

What is the 3-year average Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?

What is the 5-year average Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?

How does the current Enterprise Value for AXIM Biotechnologies, Inc. (AXIM) compare to its historical average?